Funding for this research was provided by:
BIOVISION (Biovision Foundation, Project Number. BV HH-07 / 2016-18)
Received: 24 September 2018
Accepted: 29 March 2019
First Online: 23 April 2019
Ethics approval and consent to participate
: Ethical approval for this study was granted by Kenya Medical Research Institute (KEMRI)/Scientific and Ethic Review Unit (SERU) protocol number 2675 as part of Integrated Management for sustainable malaria control in East Africa references KEMRI/RES/7/3/1.Consent to participate in this study was verbally requested from the participant during interview time, the consent was recorded in each of the household questionnaire after explaining to the participant the objective of the study and confidentiality of the information. The introduction section of the questionnaire sought to seek participant’s verbal consent to participate in the study, captured as either YES or NO, with YES indicating that the participant accepted to participate (Additional file InternalRef removed). Because of the low-risk nature of the study which did not involve taking participants biological samples, the procedure was ethically acceptable as part of integrated vector management project for malaria control in the area.The questionnaire and interview questions developed for this study had not been previously published elsewhere. Participant’s rights were respected and guaranteed during the interview time.
: Not Applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.